Investigating alpha‐synuclein oligomers in the pathogenesis of PD

Specialists have reported new findings on the distribution of alpha‐synuclein (αSYN) oligomers in the brains of patients with Parkinson’s disease.

Lewy bodies are a late-stage aggregation of αSYN, and have been considered as a pathological hallmark of PD. But it remains controversial whether Lewy bodies drive neurodegeneration, said Dr Hiroaki Sekiya from the Kobe University Graduate School of Medicine, Japan.

Presenting at MDS 2020, Dr Sekiya suggested that αSYN oligomers, the early‐stage αSYN aggregation, may play a pathogenic role.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.